CurrentRheuma
Get Weekly

Topic · page 10 of 20

Vasculitis & polymyalgia rheumatica

Giant cell arteritis, Takayasu arteritis and polymyalgia rheumatica; ANCA-associated vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis), polyarteritis nodosa, IgA vasculitis in adults, Behçet's disease, cryoglobulinemic and other vasculitis

Briefs 361–400 of 782 placed here, newest publication first

Briefs in Vasculitis & polymyalgia rheumatica

Newest publication first

  1. Arthritis Care Res (Hoboken)

    Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood‐Onset Anti‐Neutrophil Cytoplasmic Antibody‐Associated Vasculitis: An ARChiVe Registry Cohort Study

    Cohort study

  2. Rheumatology (Oxford)

    Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases

    Cohort study

  3. Clin Exp Rheumatol

    Avacopan with combined cyclophosphamide and rituximab for induction therapy in severe ANCA-associated vasculitis: retrospective observational study of 30 patients in two German referral centres

    Cohort study

  4. Rheumatology (Oxford)

    Sustained drug-free remission in giant cell arteritis

    Cohort study

  5. Clin Exp Rheumatol

    Characteristics and clustering analysis of peripheral-blood lymphocyte subsets in patients with ANCA-associated vasculitis

    Cross-sectional study

  6. Joint Bone Spine

    Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry

    Cohort study

  7. J Rheumatol

    Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse Events

    Cohort study

  8. RMD Open

    Immune checkpoint molecules performance in ANCA vasculitis

    Mechanistic study

  9. J Rheumatol

    Symptom Severity and Glucocorticoid Dosing in Patients With Polymyalgia Rheumatica and Obesity

    Secondary analysis

  10. Rheumatology (Oxford)

    Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial

    Randomized controlled trial

  11. Ann Rheum Dis

    Defects in B-lymphopoiesis and B-cell maturation underlie prolonged B-cell depletion in ANCA-associated vasculitis

    Mechanistic study

  12. Ann Rheum Dis

    Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group

    Guideline or statement

  13. Ann Rheum Dis

    Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial

    Randomized controlled trial

  14. Rheumatology (Oxford)

    Prognostic significance of tubulointerstitial macrophage density in MPO-ANCA-associated glomerulonephritis: implications for renal outcomes

    Cohort study

  15. Rheumatology (Oxford)

    Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis

    Cohort study

  16. Rheumatology (Oxford)

    Inflammation of the temporalis muscle and adjacent nerve tissue in giant cell arteritis: expanding the spectrum of inflammatory lesions

    Cohort study

  17. Clin Exp Rheumatol

    ABO blood groups and increased risk for the development of vascular involvement in Behçet's disease

    Cohort study

  18. Rheumatology (Oxford)

    Autoantibodies towards HFE and SYT5 in anti-neutrophil cytoplasm antibody-associated vasculitis relapse

    Research article

  19. Rheumatology (Oxford)

    Serial assessment of ultrasound sensitivity and scores in patients with giant cell arteritis before and 3 and 10 days after treatment

    Cohort study

  20. Clin Exp Rheumatol

    Clinical value of diagnosing ischaemic stroke in patients with Takayasu's arteritis combining multiple arterial occlusion and high-grade enhancement

    Cohort study

  21. Clin Exp Rheumatol

    Nailfold videocapillaroscopy abnormalities and vascular manifestations in Behçet's syndrome

    Cross-sectional study

  22. Rheumatology (Oxford)

    The real-world use and effectiveness of avacopan in routine practice for the treatment of ANCA vasculitis. First experiences in Spain

    Cohort study

  23. Rheumatology (Oxford)

    Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic

    Cohort study

  24. Rheumatology (Oxford)

    Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group

    Guideline or statement

  25. RMD Open

    Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies

    Mechanistic study

  26. Arthritis Res Ther

    Serum syndecan1 has the potential to reflect activity at diagnosis and predict death during follow-up in patients with ANCA-associated vasculitis

    Cohort study

  27. Lancet Rheumatol

    The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study

    Cohort study

  28. Rheumatology (Oxford)

    Ultrasonography-led multimodal diagnostic pathway for giant cell arteritis

    Diagnostic or prognostic study

  29. Lancet Rheumatol

    Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial

    Randomized controlled trial

  30. J Rheumatol

    Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

    Cohort study

  31. Rheumatology (Oxford)

    The use of intravenous methylprednisolone in giant cell arteritis: a population-based study

    Cohort study

  32. Rheumatology (Oxford)

    Low incidence of late-onset giant cell arteritis during the first year in patients with polymyalgia rheumatica–a repeated imaging study

    Cohort study

  33. Lancet Rheumatol

    Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort

    Cohort study

  34. Rheumatology (Oxford)

    Large vessel vasculitis is a risk factor for relapse only in giant cell arteritis patients without polymyalgia rheumatica

    Cohort study

  35. Rheumatology (Oxford)

    Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study

    Cohort study

  36. Rheumatology (Oxford)

    Definitions of and instruments for disease activity, remission and relapse in polymyalgia rheumatica: a systematic literature review

    Research article

  37. Rheumatology (Oxford)

    Prevalence and prognostic relevance of electrocardiographic abnormalities among patients with ANCA-associated vasculitis

    Cohort study

  38. Clin Exp Rheumatol

    Clinicopathological characteristics of severe aortic valve regurgitation caused by Behçet's syndrome

    Cohort study

  39. Arthritis Care Res (Hoboken)

    Impact of Exposure to Environmental Particulate Matter on the Onset of Giant Cell Arteritis

    Research article

  40. RMD Open

    Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica

    Diagnostic or prognostic study

All 782 Briefs in ExploreShowing Briefs 361–400 of 782, newest first